SLC2A4 and metabolic syndrome: By stimulating eNOS, activating AMP-activated protein kinase (AMPK), and promoting GLUT4 translocation, Nebivolol enhances endothelial function, induces vasodilation, and improves insulin sensitivity in patients with diabetes or metabolic syndrome [79,116,117,118].